Skip to main content

Table 2 Atypical Pap smear test results and association with specific HR-HPV types

From: Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84 – results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany

HR-HPV typea

Prevalence of atypical Pap smear test results (%, 95% CIs) according to infection with specific HR-HPV types

1983/84 cohort (n = 659)

1988/89 cohort (n = 599)

HPV status

ASC-US or more

>LSIL

CIN1+

HPV status

ASC-US or more

>LSIL

CIN1+

HPV16

Negative

3.61

2.30

1.31

Negative

2.52

0.90

0.90

(n = 609)

(2.28-5.42)

(1.26-3.83)

(0.57-2.57)

(n = 555)

(1.39-4.20)

(0.29-2.09)

(0.29-2.09)

Positive

22.00

16.00

14.00

Positive

9.09

2.27

4.55

(n = 50)

(11.53-35.96)

(7.17-29.11)

(5.82-26.74)

(n = 44)

(2.53-21.67)

(0.06-12.02)

(0.56-15.47)

HPV18

Negative

4.50

2.95

2.02

Negative

2.75

1.03

1.03

(n = 645)

(3.03-6.39)

(1.78-4.56)

(1.08-3.42)

(n = 582)

(1.58-4.43)

(0.38-2.23)

(0.38-2.23)

Positive

28.57

21.43

14.29

Positive

11.76

0

5.88

(n = 14)

(8.39-58.10)

(4.66-50.80)

(1.78-42.81)

(n = 17)

(1.46-36.44)

(0–19.51)

(0.15-28.69)

HPV31

Negative

5.22

3.48

2.37

Negative

2.78

1.04

1.04

(n = 632)

(3.62-7.26)

(2.19-5.22)

(1.33-3.88)

(n = 575)

(1.60-4.48)

(0.38-2.26)

(0.38-2.26)

Positive

0

0

0

Positive

8.33

0

4.17

(n = 27)

(0–1.28)

(0–1.28)

(0–12.77)

(n = 24)

(1.03-27.00)

(0–14.25)

(0.11-21.12)

HPV33

Negative

5.05

3.36

2.29

Negative

3.03

1.01

1.18

n = 654)

(3.50-7.01)

(2.11-5.05)

(1.29-3.75)

(n = 594)

(1.81-4.75)

(0.37-2.19)

(0.48-2.41)

Positive

0

0

0

Positive

0

0

0

(n = 5)

(0–52.18)

(0–52.18)

(0–52.18)

(n = 5)

(0–52.18)

(0–52.18)

(0–52.18)

HPV35

Negative

4.88

3.35

2.13

Negative

3.02

1.01

1.17

(n = 656)

(3.36-6.82)

(2.11-5.03)

(1.17-3.55)

(n = 597)

(1.80-4.72)

(0.37-2.17)

(0.47-2.40)

Positive

33.33

0

33.33

Positive

0

0

0

(n = 3)

(0.84-90.57)

(0–70.76)

(0.84-90.57)

(n = 2)

(0–84.19)

(0–84.19)

(0–84.19)

HPV39

Negative

4.69

2.97

2.19

Negative

3.06

1.02

1.19

(n = 640)

(3.18-6.62)

(1.80-4.60)

(1.20-3.64)

(n = 589)

(1.82-4.79)

(0.37-2.20)

(0.48-2.43)

Positive

15.79

15.79

5.26

Positive

0

0

0

(n = 19)

(3.38-39.58)

(3.38-39.58)

(0.13-26.03)

(n = 10)

(0–30.85)

(0–30.85)

(0–30.85)

HPV51

Negative

4.49

2.72

1.76

Negative

2.58

0.55

1.10

(n = 624)

(3.00-6.42)

(1.59-4.33)

(0.88-3.13)

(n = 543)

(1.42-4.29)

(0.11-1.61)

(0.41-2.39)

Positive

14.29

14.29

11.43

Positive

7.14

5.36

1.79

(n = 35)

(4.81-30.26)

(4.81-30.26)

(3.20-26.74)

(n = 56)

(1.98-17.29)

(1.12-14.87)

(0..05-9.55)

HPV52

Negative

4.89

3.15

2.21

Negative

2.80

0.70

1.05

(n = 634)

(3.35-6.87)

(1.94-4.83)

(1.21-3.68)

(n = 572)

(1.61-4.50)

(0.19-1.78)

(0.39-2.27)

Positive

8.00

8.00

4.00

Positive

7.41

7.41

3.70

(n = 25)

(0.98-26.03)

(0.98-26.03)

(0.10-20.35)

(n = 27)

(0.91-24.29)

(0.91-24.29)

(0.09-18.97)

HPV53

Negative

4.43

2.85

2.06

Negative

2.78

0.87

1.22

(n = 632)

(2.96-6.34)

(1.70-4.46)

(1.10-3.49)

(n = 575)

(1.60-4.48)

(0.28-2.02)

(0.49-2.49)

Positive

18.52

14.81

7.41

Positive

8.33

4.17

0

(n = 27)

(6.30-38.08)

(4.19-33.73)

(0.91-24.29)

(n = 24)

(1.03-27.00)

(0.11-21.12)

(0–14.25)

HPV66

Negative

4.25

2.67

1.89

Negative

2.78

0.87

1.04

(n = 636)

(2.82-6.12)

(1.56-4.25)

(0.98-3.27)

(n = 575)

(1.6-4.48)

(0.28-2.02)

(0.38-2.26)

Positive

26.09

21.74

13.04

Positive

8.33

4.17

4.17

(n = 23)

(10.23-48.41)

(7.46-43.70)

(2.78-33.59)

(n = 24)

(1.03-27.00)

(0.11-21.12)

(0.11-21.12)

  1. aHPV subtypes were counted individually. In patients with multiple HR HPV infections, the data are reported for each subtype separately, e.g. a mixed HPV16/52 infection is included in the rows for both HPV16 and for HPV52.